Clinical trial · Interventional
ExBRAC- Expressive Writing in Breast Cancer
Expressive Writing in Breast Cancer - The ExBRAC Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study is a randomized trial designed to examine whether an "expressive writing" intervention can affect the quality of life in patients recently diagnosed with breast cancer. The method "expressive writing" consists of writing about the breast cancer or other related subjects during 20 minutes, once a week for four consecutive weeks. The impact on quality of life will be assessed by having participants complete questionnaires at three different time points during the study. The questionnaire will be developed using a clinimetric approach, based on semi-structured interviews with breast cancer patients. The themes emerging from these interviews will be used to formulate the questions. Additionally, well-known quality-of-life measurement instruments and registry data with clinically relevant information-such as tumor stage and treatment-will be incorporated.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Expressive Writing | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Expressive Writing
- description
- Expressive writing for 20 minutes, once a week, for 4 consecutive weeks. The intervention is done in addition to standard care.
- interventionNames
- Behavioral: Expressive Writing
- type
- NO_INTERVENTION
- label
- Control group
- description
- No intervention. Treatment according to standard care.
Primary outcomes (1)
- measure
- Health-related quality of life
- timeFrame
- At the 12 months follow-up
- description
- According to EQ-5D-5L VAS. The scale ranges from 0-100 where 0 is "worst possible health" and 100 is "best possible health".
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Planned for surgery of breast cancer without neoadjuvant treatment Exclusion Criteria: * Not able to understand Swedish * Previous breast cancer
References
Publications (0)
Data not yet available